Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
20.9M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
+605K
-
Total reported value, excl. options
-
$67.6M
-
Value change
-
+$2.13M
-
Put/Call ratio
-
1.25
-
Number of buys
-
28
-
Number of sells
-
-29
-
Price
-
$4.37
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q1 2025
79 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 20.9M outstanding shares and own 75.71% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (2.74M shares), TCG Crossover Management, LLC (1.8M shares), FRANKLIN RESOURCES INC (1.76M shares), Principia Wealth Advisory, LLC (1.7M shares), BlackRock, Inc. (1.43M shares), Frazier Life Sciences Management, L.P. (1.07M shares), VANGUARD GROUP INC (1.03M shares), 5AM Venture Management, LLC (542K shares), GOLDMAN SACHS GROUP INC (461K shares), and GEODE CAPITAL MANAGEMENT, LLC (451K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.